NGS Resolving Diagnostic Dilemmas for Pathologists
Next-Generation Sequencing: Resolving Diagnostic Dilemmas for Pathologists
Next-Generation Sequencing (NGS) is fundamentally transforming pathology from relying on bulk morphology to achieving true precision medicine at the cellular level. Originally presented at the King Salman International University Virtual International Pathology Conference , this comprehensive, free course is designed to empower pathologists to act as the gatekeepers of tissue quality and molecular diagnostic context.
You will explore the critical shift from slow, single-gene sequential testing to massively parallel NGS analysis. The curriculum directly addresses five major diagnostic dilemmas: resolving morphologically ambiguous tumors, matching patients with precise targeted therapies, refining prognostic stratification, clarifying atypical histological "gray zones," and identifying hereditary cancer syndromes.
Furthermore, the course bridges the clinical and administrative gap by thoroughly examining the health economics of NGS. You will analyze how this technology proves its cost-effectiveness through real-world Quality-Adjusted Life-Year (QALY) gains.
Whether dealing with the challenges of FFPE tissue blocks, implementing liquid biopsies, or preparing for Artificial Intelligence integration, this course provides the strategic blueprint for building a highly efficient, inter-professional genomic workflow.
What you'll learn
- Differentiate the clinical utility of targeted panels, WES, and WGS to appropriately match NGS platforms with specific diagnostic questions.
- Apply comprehensive genomic profiling to resolve five primary diagnostic dilemmas, including tumor classification ambiguity and borderline lesion categorization.
- Evaluate the health economic impact of NGS integration, utilizing cost-utility ratios and QALY gains to justify advanced molecular testing.
- Design a collaborative, inter-professional diagnostic algorithm that seamlessly integrates histopathology, IHC, and NGS data into a single, definitive clinical report.
Whats Included
- Diagnostic Mastery: Learn how to resolve five core diagnostic dilemmas using objective molecular signatures rather than relying solely on traditional histology and IHC.
- Technology & Platform Selection: Understand when to deploy Targeted Panels, Whole Exome Sequencing (WES), or Whole Genome Sequencing (WGS) based on specific clinical needs.
- Sample Optimization Strategies: Gain techniques for maximizing the genomic yield from challenging, degraded formalin-fixed paraffin-embedded (FFPE) tissue blocks.
- Economic & Operational Blueprints: Analyze the cost-utility ratio of NGS and learn how streamlining targeted panels reduces overall laboratory costs and test volumes.
- Future-Ready Workflows: Prepare your laboratory for emerging paradigms, including real-time liquid biopsy monitoring, Tumor Mutational Burden (TMB) quantification, and AI-driven bioinformatics interpretation.
Curriculum
Frequently Asked Questions
